XTX Topco’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$527K Sell
37,555
-36,121
-49% -$506K 0.02% 1064
2025
Q1
$1.15M Buy
+73,676
New +$1.15M 0.06% 483
2024
Q4
Sell
-47,728
Closed -$444K 2265
2024
Q3
$444K Buy
47,728
+11,262
+31% +$105K 0.03% 899
2024
Q2
$339K Buy
36,466
+25,793
+242% +$240K 0.03% 882
2024
Q1
$106K Sell
10,673
-135,389
-93% -$1.34M 0.01% 1354
2023
Q4
$472K Buy
146,062
+122,602
+523% +$396K 0.1% 295
2023
Q3
$125K Buy
+23,460
New +$125K 0.02% 1152
2023
Q1
Sell
-12,222
Closed -$181K 1259
2022
Q4
$181K Buy
+12,222
New +$181K 0.04% 881